Case Comprehensive Cancer Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Case Comprehensive Cancer Center sits in the top decile of US sponsors by registered trial count (#90 of 15,742 sponsors by registered trial count).
Case Comprehensive Cancer Center: 407 sponsored US clinical trials, 55 recruiting.
Case Comprehensive Cancer Center sponsors 407 registered US clinical trials on ClinicalTrials.gov, 55 of them currently recruiting, and 257 completed. 13 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
Case Comprehensive Cancer Center ranks in the top decile of sponsors by registered trial count (#90 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
257 of 325 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
407 total, page 2 of 9
Genomic Analysis of Families With a History of Discordant Cancers
NCT04860453
Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation
NCT04332341
Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases
NCT04218617
Proton Therapy Patient Registry
NCT02986048
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
NCT01891318
Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors
NCT06336538
Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors
NCT06435871
Individualized Treatments in Adults With Relapsed/Refractory Cancers
NCT06024603
Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program
NCT05831358
Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma
NCT05209074
Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography
NCT04348123
Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer
NCT04620603
CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS
NCT04668885
Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
NCT04545177
Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC
NCT04010357
Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin Lymphoma
NCT03713580
Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
NCT03535350
Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
NCT03514069
Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions
NCT02802553
Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
NCT03277638
Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
NCT03283540
Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors
NCT02956291
Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases
NCT01843413
TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)
NCT07653594
Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS)
NCT07219745
Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)
NCT06811454
Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)
NCT06084780
Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI
NCT07040501
Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis
NCT07524634
A Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment
NCT07419581
Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations
NCT06926530
Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma
NCT07222657
Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia
NCT06824727
Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses
NCT05923060
Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)
NCT06354049
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
NCT06167096
eXtended Antibiotic Prophylaxis for Intermediate- and High-risk Glands After Pancreatoduodenectomy to Reduce CR-POPF
NCT05753735
Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses
NCT06027619
NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients
NCT05978232
The Impact of Functional Medicine On Wound Healing From Delayed Autologous Breast Reconstruction
NCT05028101
A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose
NCT05142358
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer
NCT05289830
Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms
NCT05225038
Detection of Barrett s Esophagus in Patients Without GERD Symptoms
NCT04880044
Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer
NCT04354675
Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT
NCT04194840
Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer
NCT04493034
Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program
NCT04365569
Free Flap Breast Reconstruction Using Virtual Surgical Planning and 3-D Modeling
NCT03949491
Teach-back Method on Patient Satisfaction and Adherence to Wound Care Regimen
NCT04377971
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 87 |
| Phase 2 | 116 |
| Phase 3 | 12 |
| Phase 4 | 1 |
Therapeutic Areas
What is open in the Case Comprehensive Cancer Center pipeline
55 recruiting of 407 indexed (14% open); 257 completed (63%).
Phase mix: 13 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Case Comprehensive Cancer Center: open-pipeline peers nationwide
Peers matched on 407 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Case Comprehensive Cancer Center sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 407 trials (± recruiting share)
- University of Nebraska · 407 trials · 13% recruiting
- Takeda · 408 trials · 12% recruiting
- University of Kansas Medical Center · 408 trials · 23% recruiting
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Beth Israel Deaconess Medical Center · 14% recruiting · 488 trials
- Wayne State University · 13% recruiting · 163 trials
- University of Michigan · 13% recruiting · 1,327 trials
- Albany Medical College · 13% recruiting · 52 trials
Related
What to do with this Case Comprehensive Cancer Center page
407 registered trials is a research-attention snapshot, not an endorsement of Case Comprehensive Cancer Center or any single study.
- 55 of Case Comprehensive Cancer Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Case Comprehensive Cancer Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Case Comprehensive Cancer Center pipeline card: 407 registered trials from official public datasets.Report a data error.